Advanced Search

Decision Dg No. 2013-127 Of 15 May 2013 For Delegation Of Signature To The National Agency For Safety Of The Drug And Health Products

Original Language Title: Décision DG n° 2013-127 du 15 mai 2013 portant délégation de signature à l'Agence nationale de sécurité du médicament et des produits de santé

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.

Information on this text




JORF no.0117 of 23 May 2013
text No. 12



Decision DG No. 2013-127 of May 15, 2013 with delegation of signature at the National Drug and Health Products Safety Agency

NOR: AFSM1300110S ELI: https://www.legifrance.gouv.fr/eli/decision/2013/5/15/AFSM1300110S/jo/texte


Director General of the National Drug and Health Products Safety Agency,
Vu le Public Health Codearticles L. 5311-1 et seq. and R. 5322-14;
Vu la Act No. 2011-2012 of 29 December 2011 on strengthening the health safety of the drug and health products;
Vu le Decree No. 2012-597 of 27 April 2012 the National Drug Safety Agency and Health Products;
Having regard to the decree of May 1, 2012 appointing the Director General of the National Agency for the Safety of Medicine and Health Products - Mr. Maraninchi (Dominique);
Having regard to Decision DG No. 2012-237 of 24 September 2012 organizing the National Drug Safety Agency and Health Products;
Having regard to Decisions DG No. 2012-238 of 24 September 2012 and DG No. 2012-248 of 7 November 2012 appointing the National Agency for the Safety of Drugs and Health Products;
In light of amended decision DG No. 2012-239 of 24 September 2012 with delegation of signature to the National Drug and Health Products Safety Agency;
Considering Decision DG 2013-113 of April 19, 2013 amending Decision DG No. 2012-238 of September 24, 2012 appointing the National Drug and Health Products Safety Agency;
Considering Decision DG 2013-128 of May 7, 2013 amending Decision DG No. 2012-238 of September 24, 2012 appointing the National Drug and Health Products Safety Agency;
In light of Decision DG No. 2013-137 of May 7, 2013 amending Decision DG No. 2012-238 of September 24, 2012 appointing the National Agency for Safety of Drugs and Health Products,
Decides:

Article 1


Decision DG No. 2012-239 of 24 September 2012 amended by delegation of signature to the National Agency for the Safety of Drugs and Health Products referred to above is amended as follows:
I. ― In the third of Article 12, the words: "and Mr. BORN (Jean-Christophe), head of the market surveillance inspection pole" are replaced by the words: "Mr. THOMAS (Thierry), head of the market surveillance inspection pole, and Ms. KIGER (Corinne), head of testing and vigilance inspection pole".
II. ― Article 14 I is read as follows:
"Permanent Delegation is given to Mr. LEMPEREUR (Laurent), Director, Ms. DUPERRAY (Françoise) and Ms. BARBOSA (Federal), Assistant Director, to sign, on behalf of the Director General of the National Drug Safety Agency and Health Products, all decisions within the limits of the responsibilities of the Directorate of Quality, Flows and Referentials of the National Health Agency. »
III. ― In II of Article 17, the words: "and to Mrs.COURNE (Marie-Anne), head of the drug and psychotropic product team" are replaced by the words: "and to Mr.LUCAS (Stéphane), head of the drug and psychotropic team, acting."
IV. ― Article 11 is read as follows:
"I. ― Permanent Delegation is given to Ms. DELVAL (Cécile), Director, on behalf of the Director General of the National Drug Safety Agency and Health Products, all decisions within the scope of the powers of the Evaluation Directorate.
II. ― Permanent Delegation is given to Mr. GARDETTE (Jean), Deputy Director, to the effect of signing, on behalf of the Director General of the National Drug Safety Agency and Health Products, all decisions within the scope of the powers of the Evaluation Directorate.
III. ― Permanent Delegation is given to Mr. SAWAYA (Antoine), Head of the Pharmaceutical Quality Pole, and to Mr. MASSET (Dominique), Head of the Non-Clinical and Clinical Toxicology Pole, to the effect of signing, on behalf of the Director General of the National Drug Safety Agency and Health Products, all decisions within the limits of their respective poles.
IV. ― Permanent Delegation is given to Ms.LORENCE (Annie) to the effect of signing, on behalf of the Director General of the National Agency for the Safety of Medicine and Health Products, any decisions within the scope of the direction of the evaluation relating to temporary recommendations of use (RTU). »

Article 2


This decision will be published in the Official Journal of the French Republic.


Done on 15 May 2013.


D. Maraninchi


Download the document in RTF (weight < 1MB) Facsimile (format: pdf, weight < 3.5 MB) Download the document in RDF (format: rdf, weight < 1 MB)